Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. [electronic resource]
Producer: 20030625Description: 2793-8 p. digitalISSN:- 1524-4539
- Adenoviridae -- drug effects
- Antiviral Agents -- therapeutic use
- Biopsy
- Cardiac Volume -- drug effects
- Cardiomyopathy, Dilated -- complications
- Cell Count
- Disease Progression
- Electrocardiography
- Enterovirus -- drug effects
- Female
- Heart -- drug effects
- Hemodynamics -- drug effects
- Humans
- Interferon-beta -- adverse effects
- Male
- Middle Aged
- Myocardium -- pathology
- Polymerase Chain Reaction
- Stroke Volume -- drug effects
- T-Lymphocytes -- pathology
- Treatment Outcome
- Ventricular Dysfunction, Left -- complications
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.